Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vivek Ramaswamy
Biotech
Ramaswamy-backed Ambros launches with $125M to develop pain med
Ambros is using the money to fund a phase 3 trial of Abiogen's neridronate for Complex Regional Pain Syndrome type 1.
Angus Liu
Dec 16, 2025 1:32pm
Roivant founder Ramaswamy unveils 'anti-woke' presidential bid
Feb 22, 2023 7:38am
Genevant pens $303M biobucks pact with Takeda
Aug 23, 2021 7:55am
Roivant's Ramaswamy jumps to executive chair—Chutes & Ladders
Jan 29, 2021 9:30am
Roivant CEO Ramaswamy hands reins to CFO Gline
Jan 25, 2021 10:55am
Roivant gets $200M for major push into protein degradation
Dec 7, 2020 8:55am
